Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Interest & Investment Income (2020 - 2022)

Historic Interest & Investment Income for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $1.3 million.

  • Terns Pharmaceuticals' Interest & Investment Income rose 231454.55% to $1.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 114117.65%. This contributed to the annual value of $13.3 million for FY2024, which is 300.75% up from last year.
  • Terns Pharmaceuticals' Interest & Investment Income amounted to $1.3 million in Q4 2022, which was up 231454.55% from $499000.0 recorded in Q3 2022.
  • Terns Pharmaceuticals' 5-year Interest & Investment Income high stood at $1.3 million for Q4 2022, and its period low was $1000.0 during Q3 2020.
  • Over the past 3 years, Terns Pharmaceuticals' median Interest & Investment Income value was $52500.0 (recorded in 2020), while the average stood at $194583.3.
  • Data for Terns Pharmaceuticals' Interest & Investment Income shows a peak YoY increase of 480000.0% (in 2021) and a maximum YoY decrease of 7800.0% (in 2021) over the last 5 years.
  • Terns Pharmaceuticals' Interest & Investment Income (Quarter) stood at $2000.0 in 2020, then surged by 2650.0% to $55000.0 in 2021, then skyrocketed by 2314.55% to $1.3 million in 2022.
  • Its last three reported values are $1.3 million in Q4 2022, $499000.0 for Q3 2022, and $214000.0 during Q2 2022.